Correlation Between Monopar Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Monopar Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Monopar Therapeutics and Hepion Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Monopar and Hepion is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.79 times more return on investment than Hepion Pharmaceuticals. However, Monopar Therapeutics is 1.79 times more volatile than Hepion Pharmaceuticals. It trades about 0.22 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,621 in Monopar Therapeutics on August 30, 2024 and sell it today you would earn a total of 449.00 from holding Monopar Therapeutics or generate 27.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Monopar Therapeutics |
| Hepion Pharmaceuticals |
Monopar Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Monopar Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |